Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's
Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's
Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's
Submitted by
admin
on August 30, 2015 - 2:04pm
Source:
Bizjournals.com
News Tags:
Alnylam
Amgen
The Medicines Company
PCSK9 inhibitors
ALN-PCSsc
Repatha
Praluent
Headline:
Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's
Do Not Allow Advertisers to Use My Personal information
